Drug
Dasatinib And Paclitaxel
Dasatinib And Paclitaxel: highest development phase Phase 1/2, developed by Bristol-Myers Squibb. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Bristol-Myers Squibb
Trials
| Drug | Phase | Indication |
|---|---|---|
| Dasatinib and Paclitaxel NCT00820170 | Phase 1/2 | Breast Cancer |
Latest
No recent events.
Follow Dasatinib And Paclitaxel on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.